98 related articles for article (PubMed ID: 15670372)
1. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial.
Menei P; Capelle L; Guyotat J; Fuentes S; Assaker R; Bataille B; François P; Dorwling-Carter D; Paquis P; Bauchet L; Parker F; Sabatier J; Faisant N; Benoit JP
Neurosurgery; 2005 Feb; 56(2):242-8; discussion 242-8. PubMed ID: 15670372
[TBL] [Abstract][Full Text] [Related]
2. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
[TBL] [Abstract][Full Text] [Related]
3. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study.
Menei P; Venier MC; Gamelin E; Saint-André JP; Hayek G; Jadaud E; Fournier D; Mercier P; Guy G; Benoit JP
Cancer; 1999 Jul; 86(2):325-30. PubMed ID: 10421269
[TBL] [Abstract][Full Text] [Related]
4. Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.
Menei P; Jadaud E; Faisant N; Boisdron-Celle M; Michalak S; Fournier D; Delhaye M; Benoit JP
Cancer; 2004 Jan; 100(2):405-10. PubMed ID: 14716778
[TBL] [Abstract][Full Text] [Related]
5. Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization.
Roullin VG; Mege M; Lemaire L; Cueyssac JP; Venier-Julienne MC; Menei P; Gamelin E; Benoit JP
Pharm Res; 2004 Sep; 21(9):1558-63. PubMed ID: 15497679
[TBL] [Abstract][Full Text] [Related]
6. Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma.
Roullin VG; Lemaire L; Venier-Julienne MC; Faisant N; Franconi F; Benoit JP
Anticancer Res; 2003; 23(1A):21-5. PubMed ID: 12680190
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of 5-fluorouracil-loaded microspheres on rat glioma: a magnetic resonance imaging study.
Lemaire L; Roullin VG; Franconi F; Venier-Julienne MC; Menei P; Jallet P; Le Jeune JJ; Benoit JP
NMR Biomed; 2001 Oct; 14(6):360-6. PubMed ID: 11599034
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
[TBL] [Abstract][Full Text] [Related]
9. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
Emerich DF; Winn SR; Bartus RT
Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
[TBL] [Abstract][Full Text] [Related]
10. Implantable drug-releasing biodegradable microspheres for local treatment of brain glioma.
Menei P; Benoit JP
Acta Neurochir Suppl; 2003; 88():51-5. PubMed ID: 14531561
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
Shaw E; Arusell R; Scheithauer B; O'Fallon J; O'Neill B; Dinapoli R; Nelson D; Earle J; Jones C; Cascino T; Nichols D; Ivnik R; Hellman R; Curran W; Abrams R
J Clin Oncol; 2002 May; 20(9):2267-76. PubMed ID: 11980997
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy study of novel 5-FU-loaded PMM 2.1.2-based microspheres on C6 glioma.
Fournier E; Passirani C; Vonarbourg A; Lemaire L; Colin N; Sagodira S; Menei P; Benoit JP
Int J Pharm; 2003 Dec; 268(1-2):31-5. PubMed ID: 14643974
[TBL] [Abstract][Full Text] [Related]
13. Response to a phase II study of concomitant-to-sequential use of etoposide and radiation therapy in newly diagnosed malignant gliomas.
Beauchesne P; Soler C; Boniol M; Schmitt T
Am J Clin Oncol; 2003 Jun; 26(3):e22-7. PubMed ID: 12796612
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.
Calais G; Alfonsi M; Bardet E; Sire C; Germain T; Bergerot P; Rhein B; Tortochaux J; Oudinot P; Bertrand P
J Natl Cancer Inst; 1999 Dec; 91(24):2081-6. PubMed ID: 10601378
[TBL] [Abstract][Full Text] [Related]
15. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
Beauchesne PD; Taillandier L; Bernier V; Carnin C
Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662
[TBL] [Abstract][Full Text] [Related]
16. Combined temozolomide and radiation as an initial treatment for anaplastic glioma.
Tham CK; See SJ; Tan SH; Lim KH; Ng WH; Thomas J; Chong DQ; Chua ET
Asia Pac J Clin Oncol; 2013 Sep; 9(3):220-5. PubMed ID: 23279669
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy for supratentorial malignant gliomas.
Yeh SA; Leung SW; Sun LM; Wang CJ; Fang FM; Chen HC
J Neurooncol; 1999 Apr; 42(2):183-7. PubMed ID: 10421077
[TBL] [Abstract][Full Text] [Related]
18. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P
J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy.
Gilbert MR; Friedman HS; Kuttesch JF; Prados MD; Olson JJ; Reaman GH; Zaknoen SL
Neuro Oncol; 2002 Oct; 4(4):261-7. PubMed ID: 12356356
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effectiveness of novel 5-fluorouracil-loaded poly(methylidene malonate 2.1.2)-based microspheres on F98 glioma-bearing rats.
Fournier E; Passirani C; Montero-Menei C; Colin N; Breton P; Sagodira S; Menei P; Benoit JP
Cancer; 2003 Jun; 97(11):2822-9. PubMed ID: 12767096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
